DLHCX
Price
$22.01
Change
+$0.21 (+0.96%)
Updated
Sep 26 closing price
Net Assets
636.13M
FBTAX
Price
$31.35
Change
-$0.25 (-0.79%)
Updated
Sep 25 closing price
Net Assets
1.46B
Interact to see
Advertisement

DLHCX vs FBTAX

Header iconDLHCX vs FBTAX Comparison
Open Charts DLHCX vs FBTAXBanner chart's image
Macquarie Healthcare C
Price$22.01
Change+$0.21 (+0.96%)
VolumeN/A
Net Assets636.13M
Fidelity Advisor Biotechnology A
Price$31.35
Change-$0.25 (-0.79%)
VolumeN/A
Net Assets1.46B
DLHCX vs FBTAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DLHCX vs. FBTAX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Hold and FBTAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.46B vs. DLHCX (636M). FBTAX pays higher dividends than DLHCX: FBTAX (2.59) vs DLHCX (0.00). DLHCX was incepted earlier than FBTAX: DLHCX (16 years) vs FBTAX (25 years). DLHCX (2.00) is less costly to investors than FBTAX (0.96). FBTAX is a more actively managed with annual turnover of: 73.00 vs. DLHCX (5.00). FBTAX has a lower initial minimum investment than DLHCX: FBTAX (0) vs DLHCX (1000). FBTAX annual gain was more profitable for investors over the last year : -2.30 vs. DLHCX (-17.02). FBTAX return over 5 years is better than : 4.03 vs. DLHCX (-14.58).
DLHCXFBTAXDLHCX / FBTAX
Total Expense Ratio1.960.96204%
Annual Report Gross Expense Ratio2.000.96208%
Fund Existence16 years25 years-
Gain YTD3.90815.21526%
Front LoadN/A6%-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets636M1.46B44%
Annual Yield % from dividends0.002.59-
Returns for 1 year-17.02-2.30738%
Returns for 3 years-1.4540.10-4%
Returns for 5 years-14.584.03-362%
Returns for 10 years23.3546.3050%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKMPF21.87N/A
N/A
Hikma Pharmaceuticals plc.
PMHS0.20N/A
N/A
Polomar Health Services, Inc.
SILLF0.21N/A
N/A
Sarine Technologies Ltd.
PRYMF97.17-0.83
-0.85%
Prysmian S.P.A.
SPPJY1.40-0.01
-1.06%
Sappi Ltd.